Short-term and long-term maturation of different clays for pelotherapy in an alkaline-sulphate mineral water (Rapolla, Italy)

Variations in the Texture Profile Analysis (TPA) Properties of Clay/Mineral-Medicinal Water Mixtures for Pelotherapy: Effect of Anion Type

“…Peloids are semisolid systems with a solid phase often rich in clay minerals dispersed in mineral or sea water [2,3]. The main factors controlling the characteristics of a peloid are the clay's composition and grain-size distribution and the mineral water used in the mixture [4][5][6][7][8][9].…”

Assessment of three Spanish clays for their use in pelotherapy

“…Furthermore, some properties of peloids prepared with clays, different types of water and different maturation conditions have been studied Curini et al, 1990;Fernández-González et al, 2013;Gámiz et al, 2009;Quintela et al, 2010;Sánchez et al, 2002;Tateo et al, 2010;Veniale et al, 2004). However, these studies include only some of the properties important in pelotherapy while others do not consider the modifications to these properties which occur during preparation of the clay-water mixture prior to maturation.…”

A study of the chemical, mineralogical and physicochemical properties of peloids prepared with two medicinal mineral waters from Lanjarón Spa (Granada, Spain)

“…Application of the peloid rather than the MMW would modify the acid equilibrium of the skin, which has a pH between 4.2 and 5.9 (Eberlein-König et al, 2000;Takigawa et al, 2005). These slightly alkaline Liq int of the peloids would produce effects at skin level; This is the reason why alkaline waters are often used to treat a variety of cutaneous disorders (Tateo et al, 2010).…”

“…Pelotherapy is the therapeutic use of peloids, also known as medicinal muds, and has long been practised (Tateo et al, 2010) in balneotherapy, together with treatments with medicinal mineral waters (MMWs) in spas (van Tubergen and van der Linden, 2002). MMW are those which, due to their special characteristics, have been officially recognised as therapeutic agents and declared to be of public interest by the relevant authorities .…”